VAXART INC. - COMMON STOCK

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

02 5月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart to Present at the Citizens Life Sciences Conference

30 4月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

30 4月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23

16 4月 2025 08:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

09 4月 2025 09:47:15 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

07 4月 2025 09:45:42 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

02 4月 2025 09:45:01 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

01 4月 2025 10:11:35 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

31 3月 2025 09:47:06 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

28 3月 2025 10:08:59 条件 NetDania Notify

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

27 3月 2025 11:26:13 条件 NetDania Notify

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

27 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

20 3月 2025 16:01:00 条件 Nasdaq GlobeNewswire

Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

13 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

11 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

05 3月 2025 16:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: VAXART INC. - COMMON STOCK

24 2月 2025 09:51:01 条件 NetDania Notify

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

28 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

14 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

13 1月 2025 19:55:00 条件 Nasdaq GlobeNewswire